Table 1.
Infection control strategies used
| Pediatric-treating services (n = 38) | Adult-treating services (n = 22) | p-value | ≤200 patients (n = 52) | > 200 patients (n = 8) | p-value | |
|---|---|---|---|---|---|---|
| Implementation of CF-specific infection control policy, n (%) | 37/38 (97%) | 18/22 (82%) | 0.23 | 47/50 (94%) | 8/8 (100%) | 1.00 |
| Contact precautions | ||||||
| During hospital admission: | NA | NA | NA | |||
| All people with CF, n (%) | 6/19 (32%) | 8/9 (89%) | 0.013 | |||
| MRSA infection, n (%) | 26/29 (90%) | 16/16 (100%) | 0.54 | |||
| MRO infection, n (%) | 15/21 (71%) | 11/12 (92%) | 0.22 | |||
| During ambulatory care: | NA | NA | NA | |||
| All people with CF, n (%) | 4/32 (13%) | 4/18 (22%) | 0.44 | |||
| MRSA infection, n (%) | 13/32 (41%) | 7/18 (39%) | 0.90 | |||
| MRO infection, n (%) | 9/26 (35%) | 6/18 (33%) | 0.93 | |||
| Patient mask wearing policy | 24/37 (65%) | 12/22 (55%) | 0.43 | 29/51 (57%) | 7/8 (88%) | 0.13 |
| Use of face-masks (regardless of whether mask-policy implemented): | 1.00 | 0.25 | ||||
| Surgical mask, n (%) | 22/30 (73%) | 11/14 (79%) | 27/37 (73%) | 6/7 (86%) | ||
| N95 mask, n (%) | 2/30 (7%) | 1/14 (7%) | 2/37 (5%) | 1/7 (14%) | ||
| Combination of mask types/other mask types, n (%) | 6/30 (20%) | 2/14 (14%) | 8/37 (22%) | 0/7 (0%) | ||
| Segregation strategies | ||||||
| Hospital rooms used: | 0.69 | 0.21 | ||||
| Single room with ensuite only^, n (%) | 19/31 (61%) | 10/18 (56%) | 27/43 (63%) | 2/6 (33%) | ||
| Combination of room types, n (%) | 12/31 (39%) | 8/18 (44%) | 16/43 (37%) | 4/6 (67%) | ||
| During ambulatory care: | 0.51 | 0.38 | ||||
| Segregated waiting areas, n (%) | 28/35 (80%) | 13/19 (68%) | 36/46 (78%) | 5/8 (63%) | ||
| Communal waiting areas, n (%) | 7/35 (20%) | 6/19 (32%) | 10/46 (22%) | 3/8 (38%) | ||
CF cystic fibrosis, MRO multi-drug resistant, MRSA methicillin-resistant Staphylococcus aureus; ^includes isolation rooms also (n = 1 response), NA not applicable